arrow
D

Derek D. Cyr

duke clinical research institute
H指数:26
被引数:2,885

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Structural abnormalities and effects of sacubitril/valsartan in patients with mildly reduced or preserved ejection fraction and worsening heart failure: The PARAGLIDE-HF trial

结构性异常和沙库必利/缬沙坦在轻度射血分数降低或保留及心力衰竭恶化的患者中的效果:PARAGLIDE-HF试验

2025-05-220
PRE
Stress Echocardiography in Patients With Moderate or Severe Myocardial Ischemia: Insights From the ISCHEMIA Trial

中等或重度心肌缺血患者的心脏负荷超声心动图:ISCHEMIA试验的启示

2025-03-180
PRE
In-Hospital or Out-of-Hospital Initiation of Sacubitril/Valsartan Versus Valsartan in Patients With Mildly Reduced or Preserved Ejection Fraction After A Worsening Heart Failure Event: The PARAGLIDE-HF Trial
2025-02-190
PRE
Sex Differences in Revascularization, Treatment Goals, and Outcomes of Patients With Chronic Coronary Disease: Insights From the ISCHEMIA Trial

慢性冠心病患者血运重建,治疗目标和结局的性别差异: 来自缺血试验的见解

2024-03-057
OAAI
Ischemia With Nonobstructive Coronary Arteries Insights From the ISCHEMIA Trial
2023-01-0140
OAAI
Effects of initial invasive vs. initial conservative treatment strategies on recurrent and total cardiovascular events in the ISCHEMIA trial
2021-09-139
PRE
Myocardial Infarction in the ISCHEMIA Trial Impact of Different Definitions on Incidence, Prognosis, and Treatment Comparisons
2021-02-2396
OAAI
Association of Sex With Severity of Coronary Artery Disease, Ischemia, and Symptom Burden in Patients With Moderate or Severe Ischemia Secondary Analysis of the ISCHEMIA Randomized Clinical Trial

中度或重度缺血患者的性别与冠状动脉疾病,缺血和症状负荷的严重程度的关联缺血随机临床试验的次要分析

2020-07-01111
OAAI